As of 2007, published epidemiological data for<unk>  was mostly limited to studies before the availability of second-generation antipsychotics. Prevalence rates may be lower for modern treatment as second-generation antipsychotics carry a lower risk of<unk> . Approximately one out of four individuals treated with first-generation antipsychotics have<unk> .
Akathisia
Restless legs syndrome
Tardive dyskinesia
Paroxysmal dyskinesia
Dystonia
Pseudoathetosis
Anxiety
Paroxysmal nonkinesigenic dyskinesia